‘Children with cancer cannot wait’: the human cost of clinical trial delays after Brexit

Exclusive: Price of importing drugs for a Paris and Birmingham study has almost quadrupled to £175,000NHS cancer patients denied life-saving drugs due to Brexit costs, report findsBritish clinical trials of revolutionary cancer treatments are being derailed by red tape and extra costs caused by Brexit, according to a report obtained by the Guardian.These two examples illustrate how the UK’s departure from the EU is harming UK cancer research, leaving patients in limbo and unable to access pioneering treatments. Continue reading...

‘Children with cancer cannot wait’: the human cost of clinical trial delays after Brexit

Exclusive: Price of importing drugs for a Paris and Birmingham study has almost quadrupled to £175,000

British clinical trials of revolutionary cancer treatments are being derailed by red tape and extra costs caused by Brexit, according to a report obtained by the Guardian.

These two examples illustrate how the UK’s departure from the EU is harming UK cancer research, leaving patients in limbo and unable to access pioneering treatments. Continue reading...